FDA inspection
Linhai Tianyu Pharmaceutical Co., Ltd.: FDA inspection ending Sep 15, 2023
FDA inspection 1220204 · Voluntary Action Indicated (VAI) · Taizhou
Key facts
| Inspection ID | 1220204 |
|---|---|
| Firm | Linhai Tianyu Pharmaceutical Co., Ltd. |
| FEI number | 3013345425 |
| Address | Provincial Chemical And Medical Raw Materials Base, No. 15 Donghai 5th Ave. Provincial Chem. |
| City | Taizhou |
| Country | China |
| Fiscal year | 2023 |
| Inspection end date | Sep 15, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data